mesenchymal stem cells (AC607) / AlloCure  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mesenchymal stem cells (AC607) / AlloCure
ACT-AKI, NCT01602328: A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects

Terminated
2
156
US, Canada
AC607, allogeneic bone marrow-derived human mesenchymal, stem cells, Vehicle Only
AlloCure Inc.
Acute Kidney Injury
06/14
08/14

Download Options